EP Patent

EP2055189A1 — Glycopegylation methods and proteins/peptides produced by the methods

Assigned to Novo Nordisk AS · Expires 2009-05-06 · 17y expired

What this patent protects

The invention includes methods and compositions for remodelling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.

USPTO Abstract

The invention includes methods and compositions for remodelling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.

Drugs covered by this patent

Patent Metadata

Patent number
EP2055189A1
Jurisdiction
EP
Classification
Expires
2009-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.